Ibuprofen/Sodium Cromoglicate

布洛芬/色甘酸钠

Report date: 2025/11/18 20:00:06

Base Information

Drug NameIbuprofen/Sodium Cromoglicate
Drug Alias NameCromolyn+Ibuprofen布洛芬/色甘酸Ibuprofen+Cromolyn色甘酸+布洛芬Ibuprofen/Cromolyn +[8
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsMast cells stabilizersGlial cells modulators
TargetsCyclooxygenases
Therapy Area/IndicationsIschemic StrokeCognition DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[7
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAztherapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAztherapies Inc
Active IndicationsN/A
Inactive IndicationsIschemic StrokeCognition DisordersAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A